VanEck Pharmaceutical ETF (PPH)
| 75.88 Delayed Data As of 3:59pm ET |  +0.40 / +0.53%Today’s Change | 71.04 Today|||52-Week Range 84.27 | -1.40% Year-to-Date |
Investment Objective
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS ® US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Latest PPH News
| 3 Health Care ETFs You'll Want to Own When the Market Recovers Aug 03 / StockNews.com - Paid Partner Content | Is Invesco Dynamic Pharmaceuticals ETF (PJP) a Strong ETF Right Now? Aug 03 / Zacks.com - Paid Partner Content |
Performance
| 1 month | -1.82% | 3 years | +12.07% | |
| 3 months | -1.58% | 5 years | +8.28% | |
| 1 year | +1.78% | Since inception | +9.44% |
Data through 08/06/2022
Quote Details
| Previous close | $75.48 |
| Open day’s range | 75.53 – 76.25 |
| Net asset value (NAV) | 75.50 (08/05/2022) |
| Daily volume | 7,983 |
| Average volume (3 months) | 181,866 |
Data as of 3:59pm ET, 08/08/2022
Peer Comparisonvs. Health ETFs
| PPH | Category | |
|---|---|---|
| Performance 5-yr return | +8.28% | +7.33% |
| Expense Gross exp ratio | 0.35% | 1.01% |
| Risk 5 year sharpe ratio | 0.48 | 0.48 |
| Net assets | $571.9M | $2.0B |
| Average market cap | $72.4B | $43.6B |
| Average P/E | 19.6 | 22.0 |
| Dividend / Share | -- | 0.27% |
Competitors
| VHT Vanguard Health Care Index Fund ETF Shar... |
| FHLC Fidelity MSCI Health Care Index ETF |
| IEHS iShares Evolved U.S. Healthcare Staples ... |
Holdings
Top 5 SectorsPortfolio weighting
| Business service | -- |
| Consumer goods | -- |
| Consumer service | -- |
| Energy | -- |
| Financial service | -- |
Top 10 HoldingsPortfolio weighting
| LLY Eli Lilly and Co | 5.37% |
| AZN AstraZeneca | 5.23% |
| NVO Novo Nordisk | 5.11% |
| MRK Merck | 5.10% |
| JNJ Johnson & Johnson | 5.03% |
| NVS Novartis | 5.02% |
| MCK Mckesson Corp | 4.98% |
| TAK Takeda Pharmaceutical | 4.95% |
| BMY Bristol-Myers Squibb | 4.95% |
| ABBV AbbVie | 4.91% |
